Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Abroad (travel likely)RecruitingPHASE3
Conditions
Tuberculosis · HIV
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Instituto Tropical de Doenças Infecciosas Manaus, Manaus, Amazonas, Brazil
Contact: Study coordinator (Marcus Lacerda, MD, PhD) · marcuslacerda.br@gmail.com · +55 92 99114-7633Contact: Principal Investigator (Marcus Lacerda, MD,PhD)Universidade Federal da Bahia, Salvador, Estado de Bahia, Brazil
Contact: Principal Investigator (Carlos Brites, MD, PhD)FIOCruz, Rio de Janeiro, Rio de Janeiro, Brazil
Contact: Principal Investigator (Valeria Rolla, MD)Hospital Geral de Nova Iguaçu, Rio de Janeiro, Rio de Janeiro, Brazil
Contact: Principal Investigator (Aline Ramalho, MD)CePClin - Center for Studies and Research in Infectious Diseases Ltda, Natal, Rio Grande do Norte, Brazil
RDSS- Ricardo Diaz Solucoes Cientificas, São Paulo, São Paulo, Brazil
Contact: Principal Investigator (Ricardo S Diaz, MD)
Study leads
Ethel M Weld, MD
Principal Investigator
Johns Hopkins University